The current institutional shareholding score of Corbus Pharmaceuticals Holdings Inc is 7.00, ranking 81 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 75.71%, representing a quarter-over-quarter decrease of 5.97%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.96% of shares outstanding, with 4.65% increase in holdings.